# Graft Inflow Modulation for Portal Hyper-perfusion in Live Donor Liver Transplantation

> **NCT04252794** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 75 (actual)

## Conditions studied

- Cirrhosis, Liver

## Interventions

- **PROCEDURE:** Splenic artery ligation
- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT04252794
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-08
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2024-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04252794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04252794, "Graft Inflow Modulation for Portal Hyper-perfusion in Live Donor Liver Transplantation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04252794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*